Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down 4% year-over-year.
Net income attributable to Gilead was $1 billion, or $0.80 per share, compared to $19 million, or $0.02 per share, last year. Adjusted EPS amounted to $1.37.
For the full year of 2023, the company expects adjusted EPS of $6.60-7.00.
Prior performance
Most Popular
USB Earnings: US Bancorp Q1 profit jumps on higher interest income
U.S. Bancorp (NYSE: USB) Wednesday reported a double-digit growth in first-quarter earnings, reflecting an increase in net interest income. Total net revenue increased 3.6% from last year to $7.0 billion
Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today. Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%. Net earnings grew 8.2% to
UAL Earnings: Highlights of United Airlines’ Q1 2025 financial results
Aviation giant United Airlines Holdings, Inc. (NYSE: UAL) on Tuesday announced financial results for the first quarter of 2025. Net income, on an adjusted basis, was $0.91 per share in
